Table 8 Results of a 26-week Trial of Liraglutide Injection as Add-on to Metformin and Sulfonylurea in Adult Patients with Type 2 Diabetes Mellitus a Liraglutide Injection Compared to Exenatide, Both as Add-on to Metformin and/or Sulfonylurea Therapy In this 26-week, open-label trial, 464 adult patients with type 2 diabetes mellitus on a background of metformin monotherapy, sulfonylurea monotherapy or a combination of metformin and sulfonylurea were randomized to once daily liraglutide injection 1.8 mg or exenatide 10 mcg twice daily
A monochromator (Polychrome V, TILL Photonics, FEI) combined with a xenon light bulb provided fluorescent illumination
Our veteran-owned facility offers a wide range of cutting-edge treatments and services, all designed to enhance your natural beauty and improve your overall health
Brusilow SW, Valle DL, Batshaw M
In mouse studies that investigated PPI use and the resulting severity of experimental colitis, PPIs were found to increase the severity of experimental colitis, as well as illustrated a significant increase in weight loss and disease activity index scores (Nighot et al
